新疆建设兵团
Search documents
天康生物跌2.01%,成交额5750.80万元,主力资金净流出455.36万元
Xin Lang Cai Jing· 2025-09-30 02:02
Core Points - TianKang Bio's stock price has increased by 15.48% year-to-date, but has seen a decline of 2.66% in the last five trading days [2] - The company reported a revenue of 8.847 billion yuan for the first half of 2025, representing a year-on-year growth of 10.68%, with a net profit of 338 million yuan, up 22.27% [2] - The company has distributed a total of 1.891 billion yuan in dividends since its A-share listing, with 598 million yuan distributed in the last three years [3] Company Overview - TianKang Bio, established on December 28, 2000, and listed on December 26, 2006, is located in Urumqi, Xinjiang, and specializes in the production and sales of biological vaccines for livestock, feed, and plant protein [2] - The revenue composition of TianKang Bio includes 32.20% from the pig breeding industry chain, 27.51% from feed, 16.37% from protein and oil processing, 14.75% from corn, 5.44% from veterinary drugs, and 3.40% from other sources [2] - As of September 19, 2025, the number of shareholders is 62,700, a decrease of 9.64% from the previous period, with an average of 21,770 circulating shares per person, an increase of 10.67% [2] Institutional Holdings - As of June 30, 2025, the sixth largest circulating shareholder is Guotai Zhongzheng Livestock Breeding ETF, holding 15.5491 million shares, an increase of 641,000 shares from the previous period [3] - The ninth largest circulating shareholder is Harvest Agricultural Industry Stock A, holding 10.2945 million shares, an increase of 630,100 shares [3] - The tenth largest circulating shareholder is Southern Zhongzheng 1000 ETF, holding 10.0839 million shares, an increase of 1.8978 million shares [3]
天富能源涨2.01%,成交额2.09亿元,主力资金净流出497.59万元
Xin Lang Cai Jing· 2025-09-29 02:06
Core Viewpoint - Tianfu Energy's stock has shown significant volatility, with a year-to-date increase of 34.37%, but a recent decline of 1.03% over the last five trading days, indicating potential market fluctuations and investor sentiment changes [1][2]. Financial Performance - For the first half of 2025, Tianfu Energy reported a revenue of 4.066 billion yuan, a year-on-year decrease of 10.64%, and a net profit attributable to shareholders of 304 million yuan, down 3.00% compared to the previous year [2]. - Cumulatively, since its A-share listing, Tianfu Energy has distributed a total of 1.812 billion yuan in dividends, with 293 million yuan distributed over the last three years [3]. Shareholder Structure - As of September 10, 2025, the number of shareholders for Tianfu Energy increased to 74,000, reflecting a 10.45% rise, while the average circulating shares per person decreased by 9.46% to 18,572 shares [2]. - Among the top ten circulating shareholders, Southern CSI 1000 ETF holds 8.8832 million shares, an increase of 1.6726 million shares from the previous period, while Huaxia CSI 1000 ETF is a new entrant with 5.2405 million shares [3]. Market Activity - On September 29, Tianfu Energy's stock price reached 8.62 yuan per share, with a trading volume of 209 million yuan and a turnover rate of 1.80%, resulting in a total market capitalization of 11.847 billion yuan [1]. - The stock experienced a net outflow of 4.9759 million yuan from main funds, with significant buying and selling activity from large orders [1].
天富能源跌2.08%,成交额5.73亿元,主力资金净流出2611.25万元
Xin Lang Cai Jing· 2025-09-26 05:32
Core Viewpoint - Tianfu Energy's stock has experienced fluctuations, with a year-to-date increase of 32.35% but a recent decline of 2.08% in the last five trading days, indicating volatility in market performance [1]. Financial Performance - For the first half of 2025, Tianfu Energy reported a revenue of 4.066 billion yuan, a year-on-year decrease of 10.64%, and a net profit attributable to shareholders of 304 million yuan, down 3.00% compared to the previous year [2]. - Cumulatively, since its A-share listing, Tianfu Energy has distributed a total of 1.812 billion yuan in dividends, with 293 million yuan distributed over the last three years [3]. Shareholder and Market Activity - As of August 20, 2025, the number of shareholders for Tianfu Energy was 67,000, a decrease of 0.68% from the previous period, while the average circulating shares per person increased by 0.69% to 20,513 shares [2]. - The stock's trading activity showed a net outflow of 26.1125 million yuan from major funds, with significant buying and selling activity from large orders [1]. Company Overview - Tianfu Energy, established on March 28, 1999, and listed on February 28, 2002, is primarily engaged in power and heat production, natural gas supply, urban water supply, and construction services [1]. - The company's revenue composition is as follows: 80.82% from industrial operations, 13.58% from commercial activities, 4.42% from construction, and 1.17% from other sources [1].
天康生物涨2.12%,成交额2.53亿元,主力资金净流入1201.34万元
Xin Lang Zheng Quan· 2025-09-19 03:30
Core Viewpoint - TianKang Biological has shown a significant increase in stock price and trading volume, indicating positive market sentiment and potential growth in the agricultural and livestock sector [1][2]. Company Overview - TianKang Biological Co., Ltd. is located in Urumqi, Xinjiang, and was established on December 28, 2000, with its stock listed on December 26, 2006. The company specializes in the production and sales of biological vaccines for livestock, feed, and plant protein, as well as pig breeding, pig farming, slaughter processing, and meat product sales [1]. - The revenue composition of TianKang Biological includes: 32.20% from pig farming, 27.51% from feed, 16.37% from protein and oil processing, 14.75% from corn, 5.44% from veterinary drugs, and 3.40% from other sources [1]. Financial Performance - For the first half of 2025, TianKang Biological achieved an operating income of 8.847 billion yuan, representing a year-on-year growth of 10.68%. The net profit attributable to the parent company was 338 million yuan, reflecting a year-on-year increase of 22.27% [2]. - Since its A-share listing, TianKang Biological has distributed a total of 1.891 billion yuan in dividends, with 598 million yuan distributed over the past three years [3]. Shareholder Information - As of September 10, 2025, the number of shareholders of TianKang Biological was 69,400, an increase of 1.60% from the previous period. The average number of circulating shares per person decreased by 1.57% to 19,672 shares [2]. - Notable institutional shareholders include Guotai Zhongzheng Livestock Breeding ETF, which holds 15.5491 million shares, and Jiashi Agricultural Industry Stock A, holding 10.2945 million shares, both of which have increased their holdings compared to the previous period [3].
北新路桥涨2.22%,成交额1.01亿元,主力资金净流入778.96万元
Xin Lang Cai Jing· 2025-09-05 06:22
Company Overview - Xinjiang Beixin Road and Bridge Group Co., Ltd. is located in Urumqi, Xinjiang, and was established on August 7, 2001, with its listing date on November 11, 2009 [2] - The company's main business involves construction services for public transportation infrastructure, including highway engineering (91.35%), bridge engineering, tunnel engineering, and municipal traffic engineering [2] - As of June 30, the number of shareholders is 60,600, a decrease of 6.81% from the previous period, with an average of 17,999 circulating shares per person, an increase of 7.30% [2] Financial Performance - For the first half of 2025, the company achieved operating revenue of 4.956 billion yuan, a year-on-year increase of 20.66%, while the net profit attributable to shareholders was -80.91 million yuan, a decrease of 868.68% year-on-year [2] - The company has cumulatively distributed cash dividends of 74.32 million yuan since its A-share listing, with 12.68 million yuan distributed in the last three years [3] Stock Performance - On September 5, the stock price increased by 2.22%, reaching 4.61 yuan per share, with a trading volume of 101 million yuan and a turnover rate of 1.74%, resulting in a total market capitalization of 5.847 billion yuan [1] - Year-to-date, the stock price has risen by 24.59%, with a slight increase of 0.22% over the last five trading days and a 14.96% increase over the last 60 days [1] - The company has appeared on the "Dragon and Tiger List" twice this year, with the most recent appearance on August 14, where the net buying amount was -42.25 million yuan [1]